Astellas Pharma's revenue FY 2023, by region
In the fiscal year 2023, the sales revenue of Astellas Pharma Inc. in the United States amounted to over 663 billion Japanese yen, making America the largest market of the company.
The main areas of the Japanese pharmaceutical company include urology, immunology, cardiology, and infectious diseases.